Magazine Article | August 3, 2020

Small & Emerging Outsourced Manufacturing Activities

Source: Life Science Leader

By Industry Standard Research

To better understand the outsourcing practices used by respondents’ companies, ISR asked research participants to provide an estimate for each of the activities shown below. Respondents from small and emerging biopharma companies rely heavily on CMOs for manufacturing activities. On average, 65 percent or more of the manufacturing activities listed below are outsourced. Small molecule API is outsourced at the highest rate, with 83 percent outsourced on average, and roughly two-thirds of respondents indicated 81 to 100 percent of small molecule API manufacturing is outsourced.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: